These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 19687711

  • 1. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
    Mistry RD, Schwab SH, Treat JR.
    Pediatr Emerg Care; 2009 Aug; 25(8):519-22. PubMed ID: 19687711
    [Abstract] [Full Text] [Related]

  • 2. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ, Zaoutis TE, Troxel AB, Loh A, Keren R.
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [Abstract] [Full Text] [Related]

  • 3. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
    Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA.
    Ann Emerg Med; 2008 Mar; 51(3):291-8. PubMed ID: 18222564
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.
    Walraven CJ, Lingenfelter E, Rollo J, Madsen T, Alexander DP.
    J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884
    [Abstract] [Full Text] [Related]

  • 5. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR, Golik MV, Davidson L.
    Am J Ther; 2009 Apr; 16(4):333-8. PubMed ID: 19617720
    [Abstract] [Full Text] [Related]

  • 6. Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era.
    Mistry RD, Weisz K, Scott HF, Alpern ER.
    Acad Emerg Med; 2010 Feb; 17(2):187-93. PubMed ID: 20370748
    [Abstract] [Full Text] [Related]

  • 7. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections.
    Odell CA.
    Curr Opin Pediatr; 2010 Jun; 22(3):273-7. PubMed ID: 20386450
    [Abstract] [Full Text] [Related]

  • 8. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Wanat KA, Anadkat MJ, Klekotka PA.
    J Am Acad Dermatol; 2009 Apr; 60(4):589-94. PubMed ID: 19217690
    [Abstract] [Full Text] [Related]

  • 9. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A, Raman S, Johnson M, Piehl M.
    N C Med J; 2009 Apr; 70(2):102-7. PubMed ID: 19489364
    [Abstract] [Full Text] [Related]

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J.
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract] [Full Text] [Related]

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP, Bhatt AD.
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Yamane Y, Aihara M, Tatewaki S, Matsukura S, Kanbara T, Yamakawa Y, Ikezawa Z.
    Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y, Xu J, Li F, Zhu X.
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [Abstract] [Full Text] [Related]

  • 14. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E, Köse O, Erbil AH, Nişanci M, Akar A, Gür AR.
    Pediatr Dermatol; 2005 Oct; 22(4):317-20. PubMed ID: 16060867
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.
    Cunha BA.
    Int J Antimicrob Agents; 2013 Dec; 42(6):497-9. PubMed ID: 24126085
    [Abstract] [Full Text] [Related]

  • 18. Fever, rash, and peeling skin.
    Cairns B, Rich M.
    J Fam Pract; 2011 Jan; 60(1):9-12. PubMed ID: 21209972
    [No Abstract] [Full Text] [Related]

  • 19. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
    Watanabe H, Iijima M.
    Nihon Rinsho; 2007 Oct 28; 65 Suppl 8():336-40. PubMed ID: 18072345
    [No Abstract] [Full Text] [Related]

  • 20. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Finkelstein Y, Soon GS, Acuna P, George M, Pope E, Ito S, Shear NH, Koren G, Shannon MW, Garcia-Bournissen F.
    Pediatrics; 2011 Oct 28; 128(4):723-8. PubMed ID: 21890829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.